In May, TheraCode acquired JPT Peptide Technologies, a wholly owned subsidiary of Jerini. JPT offers peptide-based products and services for vaccine development, immune monitoring, and peptide ...
Market Growing for Custom-Made Peptides July 1, 2006 July 1, 2006 (Vol. 26, No. 13) Expansion Attributed to Increased Use in Drug and Vaccine Development Continued growth and a changing landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback